PLGA-PEG-ANG-2 Nanoparticles for Blood–Brain Barrier Crossing: Proof-of-Concept Study

The treatment of diseases that affect the central nervous system (CNS) represents a great research challenge due to the restriction imposed by the blood–brain barrier (BBB) to allow the passage of drugs into the brain. However, the use of modified nanomedicines engineered with different ligands that...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoyos-Ceballos, Gina P., Ruozi, Barbara, Ottonelli, Ilaria, Da Ros, Federica, Vandelli, Maria Angela, Forni, Flavio, Daini, Eleonora, Vilella, Antonietta, Zoli, Michele, Tosi, Giovanni, Duskey, Jason T., López-Osorio, Betty L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023215/
https://www.ncbi.nlm.nih.gov/pubmed/31963430
http://dx.doi.org/10.3390/pharmaceutics12010072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023215/
https://www.ncbi.nlm.nih.gov/pubmed/31963430
http://dx.doi.org/10.3390/pharmaceutics12010072

Ejemplares similares